Potential biomarkers of long-term benefit from single-agent trastuzumab or lapatinib in HER2-positive metastatic breast cancer (Q41134799)
Jump to navigation
Jump to search
scientific article published on 13 September 2013
Language | Label | Description | Also known as |
---|---|---|---|
English | Potential biomarkers of long-term benefit from single-agent trastuzumab or lapatinib in HER2-positive metastatic breast cancer |
scientific article published on 13 September 2013 |
Statements
1 reference
Potential biomarkers of long-term benefit from single-agent trastuzumab or lapatinib in HER2-positive metastatic breast cancer (English)
1 reference
Valentina Rossi
Jeff Sperinde
Caterina Peraldo-Neia
Michela Donadio
Patricia Galván
José Baselga
Maurizio Scaltriti
13 September 2013
1 reference
1 reference
1 reference